Demetrius Peter Rizos, DO Internal Medicine - Nephrology Medicare: May Accept Medicare Assignments Practice Location: 125 Northport Ave, Belfast, ME 04915 Phone: 207-661-2018 |
Alicia Snow, NP-C Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 16 Fahy St, Belfast, ME 04915 Phone: 207-338-5440 |
Kenneth Temple Calamia, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 126 Northport Ave, Suite 106, Belfast, ME 04915 Phone: 207-505-4015 |
Dr. James C Delehanty, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16 Fahey St, Suite 208 Cobb Med. Bldg, Belfast, ME 04915 Phone: 207-338-1728 Fax: 207-338-5661 |
Faisal Jamal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 Northport Ave, Belfast, ME 04915 Phone: 207-505-4080 |
Dr. Akavaram N Reddy, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 116 Northport Ave Ste 220, Belfast, ME 04915 Phone: 207-505-4015 Fax: 207-338-8368 |
Mauricio Botero-velez, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 16 Fahy St, Belfast, ME 04915 Phone: 207-505-4304 |
Jodie Hermann, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-930-2639 Fax: 207-338-8368 |
Ms. Myra Altman, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 16 Fahey Street, Suite 107, Belfast, ME 04915 Phone: 207-338-1854 Fax: 207-338-1555 |
Dr. Stuart W Mccalley, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 116 Northport Ave Ste 218, Belfast, ME 04915 Phone: 207-930-6715 Fax: 207-930-4674 |
Mary Moran, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 16 Fahey St Ste 202, Belfast, ME 04915 Phone: 207-930-6772 Fax: 207-930-6709 |
Dr. Thomas England, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-2500 Fax: 207-505-4590 |
Dr. Paul Richard Mazur, MD, MPH Internal Medicine Medicare: Medicare Enrolled Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-5440 Fax: 207-338-6912 |
Dr. Peter Mccarren, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 45 Allyn St, Belfast, ME 04915 Phone: 207-338-4544 |
Dr. David Wells Ferguson, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-1838 Fax: 207-338-3836 |
Dr. Matthew Wall, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-930-2639 Fax: 207-338-8368 |
News Archive
By linking strings of spherical iron oxide nanoparticles and coating the resulting construct with a biocompatible polymer, a multi-institutional research team has created "nanoworms" that can better target tumors and produce stronger magnetic resonance imaging (MRI) signals than their component nanoparticles. The nanoworms also appear to be a promising vehicle for carrying anticancer drugs into tumors. The researchers published their work in the journal Advanced Materials.
More than half of all in-hospital deaths due to COVID-19 during the first six months of 2020 were among Black and Hispanic patients, according to a new study led by researchers at the Stanford University School of Medicine and Duke University.
A cluster of genes on chromosome six is the only one that plays a significant role in multiple sclerosis (MS), according to the most complete genetic study to date in the disorder, presented at the 130th annual meeting of the American Neurological Association in San Diego.
Earlier, herpes simplex virus (HSV), influenza virus A, measles virus, cytomegalovirus (CMV), and mumps virus have all been associated with after-effects of the virus that includes Parkinson's disease (PD). This list may now include SARS-CoV-2.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT-302, successfully met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA).
› Verified 6 days ago